Comments on KDIGO clinical practice guidelines for bisphosphonate treatment of chronic kidney disease

Kidney International

Volumn 78, Issue 11, 2010, Pages 1186-

  Przedlacki, Jerzy ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

BONE BIOPSY; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG USE; FRACTURE; LETTER; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 78349263011     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.349     Document Type: Letter

References (1)

1. KDIGO Clinical Practice Guidelines for the Diagnosis Evaluation Prevention Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int 2009; 76(Suppl 113): S1-S130.